01 NICARDIPINE HYDROCHLORIDE (5)
01 CHIESI (5)
01 INJECTABLE;INJECTION (1)
02 INJECTABLE;INTRAVENOUS (4)
01 20MG/200ML (0.1MG/ML) (2)
02 25MG/10ML (2.5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** (1)
03 40MG/200ML (0.2MG/ML) (2)
01 USA (5)
19
CHIESI USA INC, based in U.S.A, is a pharmaceutical company.
One of their notable products is NICARDIPINE HYDROCHLORIDE, with a corresponding application number 19734 and regulatory information .
proudly manufactured in the
approval since 2008-11-07
CHIESI USA INC's CARDENE IN 0.83% SODIUM CHLORIDE IN PLASTIC CONTAINER INJECTABLE;INTRAVENOUS, medication with 40MG/200ML (0.2MG/ML) of NICARDIPINE HYDROCHLORIDE.
18
CHIESI USA INC, based in U.S.A, is a pharmaceutical company.
One of their notable products is NICARDIPINE HYDROCHLORIDE, with a corresponding application number 19734 and regulatory information .
proudly manufactured in the
approval since 2008-07-31
CHIESI USA INC's CARDENE IN 4.8% DEXTROSE IN PLASTIC CONTAINER INJECTABLE;INTRAVENOUS, medication with 20MG/200ML (0.1MG/ML) of NICARDIPINE HYDROCHLORIDE.
17
CHIESI USA INC, based in U.S.A, is a pharmaceutical company.
One of their notable products is NICARDIPINE HYDROCHLORIDE, with a corresponding application number 19734 and regulatory information .
proudly manufactured in the
approval since 2008-11-07
CHIESI USA INC's CARDENE IN 5.0% DEXTROSE IN PLASTIC CONTAINER INJECTABLE;INTRAVENOUS, medication with 40MG/200ML (0.2MG/ML) of NICARDIPINE HYDROCHLORIDE.
16
CHIESI USA INC, based in U.S.A, is a pharmaceutical company.
One of their notable products is NICARDIPINE HYDROCHLORIDE, with a corresponding application number 19734 and regulatory information .
proudly manufactured in the
approval since 2008-07-31
CHIESI USA INC's CARDENE IN 0.86% SODIUM CHLORIDE IN PLASTIC CONTAINER INJECTABLE;INTRAVENOUS, medication with 20MG/200ML (0.1MG/ML) of NICARDIPINE HYDROCHLORIDE.
15
CHIESI USA INC, based in U.S.A, is a pharmaceutical company.
One of their notable products is NICARDIPINE HYDROCHLORIDE, with a corresponding application number 19734 and regulatory information .
proudly manufactured in the
approval since 1992-01-30
CHIESI USA INC's CARDENE INJECTABLE;INJECTION, medication with 25MG/10ML (2.5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** of NICARDIPINE HYDROCHLORIDE.